Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sleep Consolidation as a Mechanistic Pathway Linking Home-Based tDCS to Antidepressant Response (S2M-D)

NCT07572526 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT07572526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07572526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sleep Consolidation as a Mechanistic Pathway Linking Home-Based tDCS to Antidepressant Response (S2M-D)
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Recruiting
Start date
June 4, 2026
Completion date
December 31, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, major depressive disorder, major depressive episode, mdd